Can-Fite’s data will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium Can-Fite enrolls patients for its ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced data from its ...

Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics ...

Kochi: There is a steady increase in the incidence of cancer in Kerala over the past decade. From 2006 to 2008, 122 out of one lakh men were detected with cancer every year in Thiruvananthapuram. It ...

CURE created a list of the top breast cancer stories of this year, including those focused on patient-reported outcomes and ...

Can-Fite BioPharma announced that its liver-protective drug, Namodenoson, will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium. Namodenoson is currently in a Phase 3 trial for ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Agenus (AGEN – Research Report) today and set a price target of $11.00.Stay ...

GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...

SGPGI Lucknow developed a new treatment regimen combining chemotherapy and radiotherapy for gallbladder cancer. Led by Professor Sushma Agrawal, the five-year study revealed improved life expectancy ...

The battle against rectal cancer has entered an extraordinary new phase with the advent of immunotherapy, offering hope to ...

The U.S. surgeon general called for cancer warnings on alcohol on Friday, citing that one in six breast cancer cases is tied ...